.
Pharmaceutical Care of Oncology Patients in Inpatient and Outpatient Settings
Study Course Description
Course Description Statuss:Approved
Course Description Version:2.00
Study Course Accepted:10.02.2021 09:38:13
| Study Course Information | |||||||||
| Course Code: | ZFTK_047 | LQF level: | Level 7 | ||||||
| Credit Points: | 2.00 | ECTS: | 3.00 | ||||||
| Branch of Science: | Basic Sciences of Medicine, including Pharmacy; Clinical Pharmacy | Target Audience: | Clinical Pharmacy | ||||||
| Study Course Supervisor | |||||||||
| Course Supervisor: | Inga Gūtmane | ||||||||
| Study Course Implementer | |||||||||
| Structural Unit: | Department of Applied Pharmacy | ||||||||
| The Head of Structural Unit: | |||||||||
| Contacts: | Riga, Dzirciema street 16, zftk rsu[pnkts]lv, +371 67061547 | ||||||||
| Study Course Planning | |||||||||
| Full-Time - Semester No.1 | |||||||||
| Lectures (count) | 8 | Lecture Length (academic hours) | 2 | Total Contact Hours of Lectures | 16 | ||||
| Classes (count) | 4 | Class Length (academic hours) | 2 | Total Contact Hours of Classes | 8 | ||||
| Total Contact Hours | 24 | ||||||||
| Study course description | |||||||||
| Preliminary Knowledge: | Knowledge of clinical pharmacology, biochemistry, dosage form technology. | ||||||||
| Objective: | To develop an understanding of the pathway of chemotherapy and other oncology drugs from prescription to administration to the oncology patient and the role of the clinical pharmacist in this process: 1. To learn in depth the topics necessary for the work of a clinical pharmacist, such as the safe and rational use of medicinal products in oncology, dosing, including for patients with organ dysfunction, side effects and interactions of medicines, monitoring. 2. To improve students’ ability to identify and solve pharmacotherapy problems in oncology. | ||||||||
| Topic Layout (Full-Time) | |||||||||
| No. | Topic | Type of Implementation | Number | Venue | |||||
| 1 | Groups of medicines used in oncology | Lectures | 2.00 | auditorium | |||||
| 2 | Therapy for the most common diseases in oncology | Lectures | 2.00 | auditorium | |||||
| 3 | Paediatric oncology | Lectures | 1.00 | auditorium | |||||
| 4 | Adjusting the dosage of medicines in oncology | Lectures | 2.00 | auditorium | |||||
| 5 | Adjusting the dosage of medicines in oncology | Classes | 2.00 | auditorium | |||||
| 6 | Adjuvant therapies in oncology, problem solving | Lectures | 1.00 | auditorium | |||||
| 7 | Adjuvant therapies in oncology, problem solving | Classes | 2.00 | auditorium | |||||
| Assessment | |||||||||
| Unaided Work: | Attending lectures in person, independently studying the literature, solving situational problems, discussing them together in a seminar. | ||||||||
| Assessment Criteria: | Attendance of lectures and classes, active participation; homework submitted on time and done in high quality. The exam assesses the ability to independently solve situational tasks and the existing theoretical knowledge of the material presented. | ||||||||
| Final Examination (Full-Time): | Exam | ||||||||
| Final Examination (Part-Time): | |||||||||
| Learning Outcomes | |||||||||
| Knowledge: | Pharmacology of medicines used in oncology, interactions the most common drug combinations used in oncology, specifics of prescribing and administration, safe handling of cytostatic medicines in inpatient and outpatient settings, specifics of paediatric oncology. | ||||||||
| Skills: | The student will be able to solve practical tasks, clinically analyse therapy and clinical case, gain experience in the analysis of standard therapies in adult and paediatric oncology, skills in safe circulation of medicinal products. | ||||||||
| Competencies: | Knowledge of medicines used in adult and paediatric oncology, interactions and dosing, analysis of therapy. | ||||||||
| Bibliography | |||||||||
| No. | Reference | ||||||||
| Required Reading | |||||||||
| 1 | Lekciju un praktisko nodarbību materiāli | ||||||||
| Additional Reading | |||||||||
| 1 | QuapoS 5. Quality Standard for the Oncology Pharmacy Service. Published by German Society of Oncology | ||||||||
| 2 | Eudralex, Volume 4. Medicinal products for human and veterinary use, GMP // Annex 1. Manufacture of sterile products | ||||||||
| 3 | Roger Walker, Kate Whittlesea. Clinical Pharmacy and Therapeutics, 5th ed., 2012 | ||||||||
| Other Information Sources | |||||||||
| 1 | British National Formulary. 2019 | ||||||||
| 2 | British National Formulary for children | ||||||||
